Market Overview
The Global Home Dialysis Systems Market is expected to reach a value of
USD 22.5 billion by the end of 2024, and it is further anticipated to reach a market value of
USD 55.2 billion by 2033 at a
CAGR of 10.5%.
Home hemodialysis (HHD) is the controlling of hemodialysis within the patient's residence. In this process, blood travels from the patient's vascular access to a dialysis machine, where it passes through filtration to remove excess waste & fluids. The purified blood is then returned to the patient's body, which allows individuals to undergo dialysis treatment conveniently within their own homes.
Key Takeaways
- The Global Home Dialysis Systems Market is expected to grow by 32.7 billion, at a CAGR of 10.5% during the forecasted period.
- By Type, the hemodialysis segment is expected to lead in 2024 & is anticipated to dominate throughout the forecasted period.
- By Treatment, the chronic kidney disease segment is expected to have a lead throughout the forecasted period.
- By Product, the service segment is expected to come out as a dominant force during the forecasted period.
- North America is expected to hold over 39.6% share of revenue in the Global Home Dialysis Systems Market in 2024.
- Some of the use cases of home dialysis systems include improved quality of life, better clinical outcomes, and more.
Use Cases
- Convenience and Flexibility: Convenience & flexibility are provided by them to patients. Instead of having to travel to a dialysis center multiple times per week & spend many hours undergoing treatment, patients can perform dialysis at home according to their schedule, which allows patients to better integrate dialysis into their daily lives, minimizing the disruption created by frequent clinic visits.
- Improved Quality of Life: Home dialysis systems can highly enhance the quality of life for patients with CKD. By allowing patients to undergo treatment at home, they can spend more time with their families, pursue hobbies and interests, and maintain a sense of normalcy in their lives. In addition, home dialysis may provide psychological benefits by empowering patients to take control of their treatment & minimizing the stress associated with frequent clinic visits.
- Reduced Healthcare Costs: It has the potential to reduce healthcare costs associated with CKD management. While the upfront costs of implementing a home dialysis program may be significant, studies have shown that home dialysis can lead to cost savings over time compared to in-center hemodialysis. By lowering the need for clinic visits &associated overhead costs, home dialysis can be a low-cost option for healthcare providers and payers.
- Better Clinical Outcomes: Home dialysis systems may also contribute to better clinical outcomes for patients with CKD. Research has suggested that frequent, more frequent dialysis treatments performed at home may lead to better control of fluid and electrolyte balance, improved preservation of residual kidney function, & reduced risk of complications like infections and hospitalizations. By providing patients with greater flexibility & control over their treatment, home dialysis systems can help optimize dialysis therapy and enhance patient outcomes over the long term.
Market Dynamic
The main driver of the global home dialysis systems market is the growth in the number of chronic kidney diseases & end-stage renal disease (ESRD) globally. As healthcare systems look to provide more patient-centered care & reduce costs associated with traditional dialysis treatments, there's an increase in the demand for home-based dialysis solutions. In addition, developments in technology, government initiatives promoting home healthcare, & the growth in the aging population further contribute to the market's growth by supporting innovation & expanding access to home dialysis options.
However, the market facing the market experiences challenges like limited patient awareness & education about home-based treatment options, along with the initial high costs associated with setting up home dialysis infrastructure. In addition, regulatory barriers & payment limitations in certain regions may hinder the broad adoption of home dialysis solutions.
Research Scope and Analysis
By Type
Hemodialysis (HD) is expected to dominate the market in 2024 capturing the majority of global revenue. HD, the main therapy for chronic kidney failure, has a wide range of products customized for home use, like machines, dialyzers, bloodline systems, and treatment solutions. Factors like the growing incidence of acute kidney injury & development in technology are expected to drive the segment growth.
Further, peritoneal dialysis (PD) is expected to grow significantly in the coming years, as it uses the peritoneum as a natural filter & is aided by many companies offering systems & consumables for constant or automated peritoneal dialysis at home. Recent studies have indicated PD's survival advantages over HD, mainly in the initial years, along with higher patient satisfaction and lower costs. These findings are expected to drive the segment's expansion in the coming future.
By Treatment
Chronic kidney disease (CKD) is expected to dominate the market in 2024, capturing the majority of global revenue. CKD occurs when the kidneys lose function, causing a dangerous buildup of toxins & fluids in the body, often resulting in end-stage renal disease (ESRD). Common causes include conditions such as high blood pressure or diabetes. With a growth in several people affected by numerous illnesses & demographic factors like diabetes, hypertension, obesity, and aging, the number of kidney failure is expected to reach one million by 2030.
Further, the acute kidney disease segment is anticipated to experience rapid growth. Acute kidney injury (AKI) refers to a temporary loss of kidney function, often triggered by other medical conditions or treatments like organ failure, severe infections, medication side effects, or surgical procedures. Dialysis may be necessary for AKI patients to survive.
By Product
The service segment is expected to lead the market in 2024, commanding a majority of the share, which is due to the proliferation of dialysis service providers & the escalating number of end-stage renal disease (ESRD). Further many players in the industry are expanding their service portfolios by building or acquiring new dialysis centers globally, further driving the growth of this segment. Also, technological developments and manufacturers' initiatives are expected to accelerate the industry's growth trajectory.
Further, the consumables segment is expected to witness the highest growth throughout the forecast period, as governments are expected to make significant investments aimed at improving patient safety, efficacy, and patient-centered care. Companies are building catheters using advanced materials resistant to many chemicals, prolonging their lifespan & reducing failure risks. The growth in demand for antimicrobial-coated catheters is reducing bloodstream infection risks, while innovations in dialyzer manufacturing technologies, like better surface contact & cutoff membrane dialyzers, are driving growth in the consumables sector, which includes bloodlines, concentrates, catheters, and other essential items.
The Home Dialysis Systems Market Report is segmented on the basis of the following:
By Type
- Hemodialysis
- Conventional
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
- Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Ambulatory Peritoneal Dialysis (APD)
By Treatment
- Acute Kidney Disease
- Chronic Kidney Disease
By Product
- Device
- Machine
- Dialyzers
- Water Treatment System
- Others
- Consumables
- Bloodlines
- Concentrates
- Catheters
- Others
Regional Analysis
North America is expected to lead the home dialysis systems market in 2024, accounting for over 39.6% of total revenue, which is fueled by substantial government investments in innovative medical devices, the presence of key industry players, & favorable reimbursement policies. The region's growth in healthcare spending, high disposable income, & proactive government measures also drive market growth, driven by a growing number of chronic kidney diseases (CKD) & increasing need for home dialysis solutions.
In addition, the Asia Pacific region is expected to witness the fastest growth during the forecast period. Factors like a burgeoning elderly population, growing cases of kidney failure, & development in product development contribute to this growth trajectory. In addition, initiatives by governments, increased healthcare spending, awareness campaigns on CKD, and the establishment of modern healthcare facilities further support market expansion, mainly in Southeast Asia where diabetes occurrence is projected to rise significantly.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The global home dialysis system market experiences intense competition among various providers providing a variety of solutions. These solutions include both peritoneal dialysis & home hemodialysis machines. As fast technological developments & increasing need for convenient dialysis options are key drivers of competition in this market.
Some of the prominent players in the global Home Dialysis Systems Market are:
- DaVita
- Cantel Medical
- Outsel Medical
- B Fresenius Medical Care
- AWAK Technologies
- Baxter International Inc
- Quanta Dialysis Technologies
- Europlaz Technologies Ltd
- Other Key Players
Recent Developments
- In September 2023, Quanta Dialysis Technologies announced the expansion of the Quanta Dialysis System, a compact and easy-to-use hemodialysis device, which is currently indicated for use in chronic and acute care settings. The new submission seeks to expand use to include self-care and in-home hemodialysis.
- In August 2023, Fresenius Medical Care unveiled the U.S. FDA approval for VersiHD with GuideMe Software, a completely reinvented self-guided interface for the company’s VersiHD chronic home hemodialysis (HHD) system, which aims to transform the experience of HHD for patients & nurses.
- In April 2023, Medtronic plc and DaVita Inc together launched Mozarc Medical an independent company committed to reshaping kidney health & driving patient-centered technology solutions, which focus on meaningful & innovative kidney health technologies that enhance the complete patient experience & increase access to care globally.
- In February 2023, The National Kidney Foundation (NKF) unveiled its recent investment from the Innovation Fund, aiming to assist Relavo, a female-founded company aimed at enhancing accessibility to home dialysis. The investment will help in advancing PeritoneX technology for safer peritoneal dialysis (PD) for patients.
Report Details
| Report Characteristics |
| Market Size (2024) |
USD 22.5 Bn |
| Forecast Value (2033) |
USD 55.2 Bn |
| CAGR (2023-2032) |
10.5% |
| Historical Data |
2018 – 2023 |
| Forecast Data |
2024 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Type (Hemodialysis and Peritoneal Dialysis), By
Treatment (Acute Kidney Disease and Chronic Kidney
Disease), By Product (Device, Consumables, and
Service) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
DaVita, Cantel Medical, Outsel Medical, B Fresenius
Medical Care, AWAK Technologies, Baxter
International Inc, Quanta Dialysis Technologies,
Europlaz Technologies Ltd, and Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users), and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Home Dialysis Systems Market size is estimated to have a value of USD 22.5 billion in 2024
and is expected to reach USD 55.2 billion by the end of 2033.
North America is expected to have the largest market share in the Global Home Dialysis Systems Market
with a share of about 39.6% in 2024.
Some of the major key players in the Global Home Dialysis Systems Market are DaVita, Cantel Medical,
Outsel Medical, and many others.
The market is growing at a CAGR of 10.5 percent over the forecasted period.